Ark Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$461K Buy
384
+69
+22% +$70.5K 0.41% 72
2026
Q1
$290K Buy
315
+17
+6% +$17.2K 0.29% 74
2025
Q4
$320K Buy
+298
New +$285K 0.34% 66

Other funds holding LLY

Ark Wealth Advisors's LLY Position: Q2 2026 in Review

Ark Wealth Advisors increased its Eli Lilly (LLY) stake by 22% in Q2 2026, buying an estimated $70.5K and bringing the position to 384 shares worth $461K. The position accounts for 0.41% of the portfolio, ranked #72.

Ark Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ark Wealth Advisors held 384 shares of Eli Lilly worth $461K as of Q2 2026.
  • Ark Wealth Advisors bought 69 Eli Lilly shares in Q2 2026, an estimated $70.5K.
  • Eli Lilly made up 0.41% of Ark Wealth Advisors's portfolio in Q2 2026, its #72 holding.
  • Ark Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ark Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.